Greatmark Investment Partners, Inc. Theratechnologies Inc. Transaction History

Greatmark Investment Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$0.83 - $2.3 $8,300 - $23,000	10,000 Added 15.27%	75,500 $66,000
Q2 2021 Aug 23, 2021	BUY	$3.43 - $3.96 $8,575 - $9,900	2,500 Added 3.97%	65,500 $254,000
Q1 2021 May 04, 2021	BUY	$2.2 - $3.94 $138,600 - $248,220	63,000 New	63,000 $243,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $135M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.